| Dr Gary W Thomas, MD | |
|
45 Hospital Center Cmns, Hilton Head Island, SC 29926-2837 | |
| (843) 699-2895 | |
| (843) 689-9270 |
| Full Name | Dr Gary W Thomas |
|---|---|
| Gender | Male |
| Speciality | Hematology |
| Experience | 37 Years |
| Location | 45 Hospital Center Cmns, Hilton Head Island, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043218316 | NPI | - | NPPES |
| P00056823 | Other | SC | RAILROAD MEDICARE |
| G07329 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 33470 (Georgia) | Secondary |
| 207RH0003X | Internal Medicine - Hematology & Oncology | 14194 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Candler Hospital | Savannah, GA | Hospital |
| Hilton Head Regional Medical Center | Hilton head island, SC | Hospital |
| Beaufort County Memorial Hospital | Beaufort, SC | Hospital |
| Coastal Carolina Hospital | Hardeeville, SC | Hospital |
| St Joseph's Hospital - Savannah | Savannah, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| South Carolina Cancer Specialists | 9032007760 | 7 |
News Archive
Castration-resistant prostate cancer (CRPC), defined as tumor progression despite castrate levels of testosterone, develops in many prostate cancer patients treated with androgen-deprivation therapy. Current treatment regimens are complicated by toxicities and a low rate of relapse-free survival. Many novel therapies in clinical trials offer hope for patients with this challenging diagnosis. Healthcare professionals who are treating CRPC must stay abreast of these emerging therapies to ensure optimal care for these patients.
Southampton Hospital announced today that Jenny and John Paulson have donated $5 million to fund a new Emergency Department. The gift is the largest in the Hospital's history and will enable the Hospital to almost double the existing space and greatly expand its delivery of emergency care to residents and visitors of the South Fork of Long Island.
Koronis Pharmaceuticals, Inc. has announced the issuance of U.S. Patent No. 7,244,732 that discloses the composition of KP-1461 - the Company's lead antiviral therapeutic currently in a Phase 2 trial for the treatment of human immunodeficiency virus (HIV) infection.
University of Kansas researchers have found that the infants of mothers who were given 600 milligrams of the omega-3 fatty acid DHA during pregnancy weighed more at birth and were less likely to be very low birth weight and born before 34 weeks gestation than infants of mothers who were given a placebo. This result greatly strengthens the case for using the dietary supplement during pregnancy.
The National Institutes of Health (NIH) has awarded nearly $3 million to support Rush University Medical Center's study analyzing how human breast milk impacts the health outcomes and health care cost savings for very low birth weight infants – babies less than 1500 grams.
› Verified 7 days ago
| Entity Name | South Carolina Cancer Specialists |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912177239 PECOS PAC ID: 9032007760 Enrollment ID: O20040305000281 |
News Archive
Castration-resistant prostate cancer (CRPC), defined as tumor progression despite castrate levels of testosterone, develops in many prostate cancer patients treated with androgen-deprivation therapy. Current treatment regimens are complicated by toxicities and a low rate of relapse-free survival. Many novel therapies in clinical trials offer hope for patients with this challenging diagnosis. Healthcare professionals who are treating CRPC must stay abreast of these emerging therapies to ensure optimal care for these patients.
Southampton Hospital announced today that Jenny and John Paulson have donated $5 million to fund a new Emergency Department. The gift is the largest in the Hospital's history and will enable the Hospital to almost double the existing space and greatly expand its delivery of emergency care to residents and visitors of the South Fork of Long Island.
Koronis Pharmaceuticals, Inc. has announced the issuance of U.S. Patent No. 7,244,732 that discloses the composition of KP-1461 - the Company's lead antiviral therapeutic currently in a Phase 2 trial for the treatment of human immunodeficiency virus (HIV) infection.
University of Kansas researchers have found that the infants of mothers who were given 600 milligrams of the omega-3 fatty acid DHA during pregnancy weighed more at birth and were less likely to be very low birth weight and born before 34 weeks gestation than infants of mothers who were given a placebo. This result greatly strengthens the case for using the dietary supplement during pregnancy.
The National Institutes of Health (NIH) has awarded nearly $3 million to support Rush University Medical Center's study analyzing how human breast milk impacts the health outcomes and health care cost savings for very low birth weight infants – babies less than 1500 grams.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gary W Thomas, MD 45 Hospital Center Cmns, Hilton Head Island, SC 29926-2837 Ph: (843) 689-2895 | Dr Gary W Thomas, MD 45 Hospital Center Cmns, Hilton Head Island, SC 29926-2837 Ph: (843) 699-2895 |
News Archive
Castration-resistant prostate cancer (CRPC), defined as tumor progression despite castrate levels of testosterone, develops in many prostate cancer patients treated with androgen-deprivation therapy. Current treatment regimens are complicated by toxicities and a low rate of relapse-free survival. Many novel therapies in clinical trials offer hope for patients with this challenging diagnosis. Healthcare professionals who are treating CRPC must stay abreast of these emerging therapies to ensure optimal care for these patients.
Southampton Hospital announced today that Jenny and John Paulson have donated $5 million to fund a new Emergency Department. The gift is the largest in the Hospital's history and will enable the Hospital to almost double the existing space and greatly expand its delivery of emergency care to residents and visitors of the South Fork of Long Island.
Koronis Pharmaceuticals, Inc. has announced the issuance of U.S. Patent No. 7,244,732 that discloses the composition of KP-1461 - the Company's lead antiviral therapeutic currently in a Phase 2 trial for the treatment of human immunodeficiency virus (HIV) infection.
University of Kansas researchers have found that the infants of mothers who were given 600 milligrams of the omega-3 fatty acid DHA during pregnancy weighed more at birth and were less likely to be very low birth weight and born before 34 weeks gestation than infants of mothers who were given a placebo. This result greatly strengthens the case for using the dietary supplement during pregnancy.
The National Institutes of Health (NIH) has awarded nearly $3 million to support Rush University Medical Center's study analyzing how human breast milk impacts the health outcomes and health care cost savings for very low birth weight infants – babies less than 1500 grams.
› Verified 7 days ago
Dr. Stephen Sean Luther, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 460 William Hilton Pkwy, Hilton Head Island, SC 29926 Phone: 843-738-4800 Fax: 843-738-4801 | |
Dr. Benjamin J Kessler, DO Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 25 Hospital Center Blvd, Hilton Head Island, SC 29926 Phone: 843-689-8141 Fax: 843-689-8112 | |
John E. Flannery Jr., M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 25 Hospital Center Blvd, Hilton Head Island, SC 29926 Phone: 843-784-8224 | |
Areadne Soler, M.D. Hematology & Oncology Medicare: May Accept Medicare Assignments Practice Location: 25 Hospital Center Blvd, Hilton Head Island, SC 29926 Phone: 786-426-7131 | |
Dr. Roger Kenneth Hershline, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 3 Pender Ln, Hilton Head Island, SC 29928 Phone: 888-935-7539 Fax: 843-342-5924 | |
Dr. Benjamin R Trotter, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 18 Hospital Center Blvd, Hilton Head Island, SC 29926 Phone: 843-681-9355 Fax: 843-842-9700 |